17,283 followers
Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume: Background Anti-PD-(L)1 treatment is indicated for patients with mismatch repair-deficient (MMRD) tumors, regardless of tumor… #oncology https://t.co/AmbFp